Boston Scientific Corporation (BSX) M&A Call Transcript

Core Viewpoint - Boston Scientific has announced an agreement to acquire Penumbra, indicating a strategic move to enhance its portfolio in the medical device industry [2]. Group 1: Acquisition Details - The acquisition of Penumbra was officially announced in a press release earlier in the day [2]. - A presentation detailing the acquisition is available on the Investor Relations section of Boston Scientific's website [2]. Group 2: Leadership Involvement - The investor update features key executives including Mike Mahoney (Chairman and CEO), Jon Monson (CFO), and Adam Elsesser (CEO of Penumbra) [2]. - Additional executives participating in the Q&A session include Joe Fitzgerald (Executive Vice President and Group President, Cardiovascular) and Dr. Michael R. Jaff (Chief Medical Officer) [2].